Moderna says its COVID-19 vaccine is effective in teenagers
The company will seek FDA approval next month.
Sean Keane Former Senior Writer
Sean knows far too much about Marvel, DC and Star Wars, and poured this knowledge into recaps and explainers on CNET. He also worked on breaking news, with a passion for tech, video game and culture.
Expertise Culture, Video Games, Breaking News
Moderna seeks to expand the use of its vaccine.
Moderna's coronavirus vaccine is effective in 12- to 17-year-olds, the company said Tuesday. The pharmaceuticals maker will apply to the US Food and Drug Administration in June for approval to administer its vaccine to teenagers.
The Pfizer vaccine has already been approved for use in teenagers.
More than 121 million doses of Moderna's vaccine had been administered in the US as of Monday, according to data from the Centers for Disease Control and Prevention, and nearly 53 million people have been fully vaccinated with it.
See also: COVID-19 vaccine side effects: What's normal and what to look out for
Other Wellness Guides
Personal Care
Sleep
Fitness
Nutrition
Medical and Mental Health
Personal Care Coupons